Syrrx Completes $54 Million in Private Financing | GenomeWeb

NEW YORK, Jan 8 – Structural genomics company Syrrx expects to close a $54 million Series C round of venture funding Tuesday, the company announced Monday.

This financing effort follows an October 3 announcement that Syrrx had raised $20 million in Series B venture funding. The San Diego-based company has raised $79 million to date

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.